In 2004 we acquired CMPMedica and said that we did not expect the acquisition to achieve a return equal to our cost of capital in its first year, but that we expected its returns to improve. The actual 2005 return on capital slightly exceeded our expectations, and we made a bolt-on acquisition of France Medical Press & Services. Combined, the pre-tax return on the CMPMedica business was 10% on a proforma basis.
2005 acquisitions contributed operating profit of £5.9m since acquisition and achieved a return of 17.7% on a proforma basis.
The performance of organic investments improved in 2005, with both revenue and operating profit increasing in line with expectations. In 2005 we achieved underlying revenue growth of 4.1% (2004: 3.2%) and we aim to accelerate that growth with further investment in 2006.
Impairment
We have reviewed the carrying value of our intangible assets (including goodwill) in light of current trading conditions and expectations and consider that no provision for impairment is required in the current year.
Pensions
The Group operates a number of defined benefit and defined contribution schemes based primarily in the UK but with some based overseas. The most recent actuarial valuations were undertaken at various points during 2005 and updated to 31 December 2005 using the projected unit method.
At 31 December 2005 the aggregate deficit under IAS 19 had decreased significantly to £52.3m from £96.0m, reflecting £17.2m of additional contributions made by the Group, strong asset returns, offset by adoption of more conservative assured mortality tables (longer life expectancy assumed) and a decrease in the discount rate used to value liabilities.
Additional contributions of £4.9m have been made in the first few months of 2006.
The IAS 19 interest charge was £2.5m in line with our expectations, reduced from £3.4m in 2004 reflecting the lower aggregate deficit.
Funding and financial risk management
The Group’s central treasury is principally concerned with managing internal and external funding requirements, the monitoring of working capital and the management of key financial market risks. Its activities are carried out in accordance with policies approved by the Board and are subject to regular review and audit. Contracts are entered into with approved counter parties and not on a speculative basis.
Following the disposals of NOP, five and others, partially offset by returns of capital to investors and acquisitions made during 2005, the Group has moved from a net debt position at the end of 2004 to a net cash position at the end of 2005. Net cash at the end of 2005 was £246.8m.
The Group borrows and invests centrally on behalf of its subsidiaries with the aim of maximising liquidity, security, flexibility and price competitiveness.
The Group’s debt at the end of 2005 is £242.6m (2004: £448.7m) comprising $165.4m of convertible bonds repayable in 2006, $5.7m of US senior notes, and €198.0m drawn from the Group’s £325m revolving credit facility. In 2005 the Group repurchased from surplus cash $234.6m of 2.375% convertible bond, and $179.3m of 7.75% US senior notes (for details on redemption and conversion and repurchases see note 21 on page 76).
Since 2002 the Group has repaid $625m of capital market debt from surplus cash. This debt carried an annual fixed cost of $47.5m per annum (average interest rate of 7.6%). The repayment of debt has significantly reduced the Group’s net interest costs.
The core bank facility was refinanced in 2005 raising funds for a further five years at lower cost, and on improved terms. The facility size was lowered from £500m to £325m reflecting the availability of liquid cash following disposals. The drawn margin on the new facility is 32.5 basis points.
The Group has established and retains strong relationships with a number of banks and financial institutions to facilitate future funding requirements and to ensure a balanced spread.
The Group’s debt contains a single financial covenant relating to interest cover.
Cash and short term liquid funds total £489.4m (2004: £379.9m) and are mainly short-term deposits with relationship banks or investments in AAA-rated money market funds. The Group operates strict investment guidelines with respect to surplus cash with the emphasis on the preservation of capital.
Exposure to interest rates is managed through the use of interest rates swaps. At the end of 2005, £436m (sterling equivalent) of interest rates swaps are outstanding with an average maturity of two years. All interest rate swaps require approval by the Finance Committee which includes the Group Chief Executive and the Chief Financial Officer.
Foreign currency transaction exposures are covered as they arise using forward foreign exchange contracts. There are no material contacts outstanding at the end of 2005. We do not hedge profits as they are accounting rather than cash exposures. Foreign currency borrowings are used where appropriate to provide a hedge against investment in overseas territories.
Our long-term credit rating remains investment grade with a Moody rating of Baa2 and Standard and Poor’s of BBB-, both with a stable outlook.
Going concern
Having reviewed the Group’s liquid resources, borrowing facilities and cash flow forecast, the directors believe that the Group has adequate resources to continue as a going concern for the foreseeable future. |